• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次接受 HIV 暴露前预防咨询时使用 PrEP 的人群特征:CSL-PrEP 队列研究。

Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.

机构信息

Infectious Diseases Unit, San Raffaele Hospital, Milano, Italy

Infectious Diseases Unit, Vita-Salute San Raffaele University, Milano, Italy.

出版信息

BMJ Open. 2022 Dec 20;12(12):e067261. doi: 10.1136/bmjopen-2022-067261.

DOI:10.1136/bmjopen-2022-067261
PMID:36600429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9772673/
Abstract

OBJECTIVES

Pre-exposure prophylaxis (PrEP) is effective for HIV prevention and is mostly used by men who have sex with men (MSM). The aim of this study was to describe the characteristics of a cohort of PrEP users at first PrEP counselling visits (baseline, BL).

DESIGN

Cross-sectional study of a cohort of MSM receiving PrEP (Centro San Luigi, CSL-PrEP Cohort).

SETTING

Secondary-level sexually transmitted infections (STI) centre in Milan, Italy, from May 2017 to May 2022.

PARTICIPANTS

Overall, 624 MSM PrEP users were included; most users were Caucasian (97%), attended university (64%), with a median BL age of 34.5 years.

RESULTS

Overall, 45% choose the daily-based PrEP regimen, 55% the event-based one. An increasing trend in PrEP counselling visits was observed (p=0.024). The majority had between 10 and 19 partners in the 3 months before BL and 41% were chemsex users. All had a HIV Incidence Risk Index for MSM (HIRI-MSM)>10, 54% between 20 and 29. Overall, 50% had ≥1 previous STI and 22% ≥1 BL STI. BL chlamydia (10%) was often more frequent than in the past (7%). The number of sexual partners was associated with BL chlamydia (p<0.001), gonorrhoea (p=0.002) and syphilis (p=<0.001), HIRI-MSM with chlamydia (p=0.001) and gonorrhoea (p=0.008), chemsex use with chlamydia (p=0.003) and gonorrhoea (p=0.030).

CONCLUSIONS

We observed an unbalanced access to PrEP in respect to all key populations which might benefit from PrEP, with a similar choice for event-based or daily-based regimens. High-risk behaviours and STIs were frequently observed. History of chlamydia was very frequently high in asymptomatic MSM at BL, compared with what observed before access to PrEP. High-risk behaviours and HIRI-MSM were associated with most of STIs.

摘要

目的

暴露前预防(PrEP)对 HIV 预防有效,主要用于男男性行为者(MSM)。本研究旨在描述首次接受 PrEP 咨询时(基线,BL)PrEP 使用者队列的特征。

设计

米兰二级性传播感染(STI)中心的 MSM 接受 PrEP 的队列研究(Centro San Luigi,CSL-PrEP 队列)。

地点

意大利米兰,2017 年 5 月至 2022 年 5 月。

参与者

共纳入 624 名 MSM PrEP 使用者;大多数使用者为白人(97%),上过大学(64%),BL 时的中位年龄为 34.5 岁。

结果

总体而言,45%的人选择了每日方案,55%的人选择了按需方案。PrEP 咨询访问量呈上升趋势(p=0.024)。大多数人在 BL 前 3 个月有 10-19 个性伴侣,41%的人使用化学性行为。所有人的男男性行为者 HIV 感染风险指数(HIRI-MSM)均>10,54%在 20-29 之间。总体而言,50%的人有≥1 次既往性传播感染,22%的人在 BL 时有≥1 次性传播感染。BL 时的衣原体(10%)感染频率高于既往(7%)。性伴侣数量与 BL 时的衣原体(p<0.001)、淋病(p=0.002)和梅毒(p<0.001)、HIRI-MSM 与衣原体(p=0.001)和淋病(p=0.008)、化学性行为与衣原体(p=0.003)和淋病(p=0.030)有关。

结论

我们观察到 PrEP 在所有可能受益于 PrEP 的关键人群中存在不平衡的获得情况,且对按需或每日方案的选择相似。高危行为和性传播感染频繁发生。无症状 MSM 在 BL 时的衣原体既往史非常高,高于 PrEP 前的观察结果。高危行为和 HIRI-MSM 与大多数性传播感染有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/9772673/436ce39c03ce/bmjopen-2022-067261f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/9772673/75868b805745/bmjopen-2022-067261f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/9772673/436ce39c03ce/bmjopen-2022-067261f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/9772673/75868b805745/bmjopen-2022-067261f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7c2/9772673/436ce39c03ce/bmjopen-2022-067261f02.jpg

相似文献

1
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.首次接受 HIV 暴露前预防咨询时使用 PrEP 的人群特征:CSL-PrEP 队列研究。
BMJ Open. 2022 Dec 20;12(12):e067261. doi: 10.1136/bmjopen-2022-067261.
2
HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.HIV 暴露前预防和性传播感染诊断 - 来自德国检查站的观察数据,2019 年 1 月至 2021 年 8 月。
BMC Public Health. 2023 Apr 7;23(1):661. doi: 10.1186/s12889-023-15570-6.
3
Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.每日用药和按需用药预防(PrEP)的男男性行为者(MSM)的性行为和性传播感染发生率:阿姆斯特丹 PrEP(AMPrEP)示范项目队列的四年随访。
PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. eCollection 2024 May.
4
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.在使用 PrEP 的情况下的性传播感染:德国男男性行为者中不同解剖部位的衣原体、淋病和支原体的高流行率。
BMC Infect Dis. 2020 Feb 7;20(1):110. doi: 10.1186/s12879-020-4831-4.
5
Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.定量评估男男性行为者在暴露前预防措施前后性行为和性传播感染分布的异质性。
Sex Transm Infect. 2022 Sep;98(6):395-400. doi: 10.1136/sextrans-2021-055227. Epub 2021 Oct 29.
6
Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.每日用药和按需用药预防方案下男男性行为者的性行为特征和艾滋病毒及性传播感染发病率:AMPrEP 研究两年结果。
Lancet HIV. 2019 Jul;6(7):e447-e455. doi: 10.1016/S2352-3018(19)30136-5. Epub 2019 Jun 6.
7
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.2020 年德国接受暴露前预防(PrEP)的人群中 HIV 感染和性传播感染发病率较低。
Infection. 2023 Jun;51(3):665-678. doi: 10.1007/s15010-022-01919-3. Epub 2022 Sep 27.
8
Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: a multivariable prediction model using causal inference methodology.在英国,与男性发生性关系的男性中的化学性行为与梅毒、淋病和衣原体的诊断:使用因果推理方法的多变量预测模型。
Sex Transm Infect. 2021 Jun;97(4):282-289. doi: 10.1136/sextrans-2020-054629. Epub 2021 Jan 15.
9
Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).加拿大暴露前预防(PrEP)使用者的性行为与性传播感染的发生率在 l'Actuel PrEP 队列中(2013-2020 年)。
Sex Transm Infect. 2022 Dec;98(8):549-556. doi: 10.1136/sextrans-2021-055215. Epub 2022 Jan 17.
10
Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.性传播感染的发生率及与行为因素的关系:大型暴露前预防(PrEP)队列的事件时间分析。
HIV Med. 2024 Jan;25(1):117-128. doi: 10.1111/hiv.13543. Epub 2023 Sep 28.

引用本文的文献

1
Four-Year Experience of HIV Pre-exposure Prophylaxis (PrEP) from an Italian Multicentre Cohort: Incidence of Sexually Transmitted Infections and Renal Toxicity.来自意大利多中心队列的四年艾滋病病毒暴露前预防(PrEP)经验:性传播感染发病率和肾毒性
AIDS Behav. 2025 May 22. doi: 10.1007/s10461-025-04736-5.
2
The Rise of Syphilis Infections and Reinfections over a Decade (2009-2019) in the Bolognese Area: A Retrospective Analysis.博洛尼亚地区十年间(2009 - 2019年)梅毒感染与再感染情况的上升:一项回顾性分析
Microorganisms. 2025 Jan 27;13(2):285. doi: 10.3390/microorganisms13020285.

本文引用的文献

1
High prevalence of anal papillomavirus infection in men who have sex with men PrEP users.男男性行为者艾滋病暴露前预防(PrEP)使用者中肛门乳头瘤病毒感染的高流行率
Sex Transm Infect. 2022 Jul 26. doi: 10.1136/sextrans-2022-055447.
2
PrEP user profiles, dynamics of PrEP use and follow-up: a cohort analysis at a Belgian HIV centre (2017-2020).PrEP 用户特征、PrEP 使用和随访的动态:比利时艾滋病毒中心的队列分析(2017-2020 年)。
J Int AIDS Soc. 2022 Jul;25(7):e25953. doi: 10.1002/jia2.25953.
3
Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.
每日按需服用恩曲他滨和替诺福韦地索普西(ANRS PREVENIR)进行艾滋病毒暴露前预防:一项前瞻性观察队列研究。
Lancet HIV. 2022 Aug;9(8):e554-e562. doi: 10.1016/S2352-3018(22)00133-3. Epub 2022 Jun 27.
4
Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.在 SARS-CoV-2 大流行期间使用 HIV 暴露前预防药物的男男性行为者的心理健康和性健康变化:瑞士 PrEPared 队列研究的纵向分析。
Swiss Med Wkly. 2022 Jun 27;152:w30192. doi: 10.4414/smw.2022.w30192. eCollection 2022 Jun 20.
5
Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.接受暴露前预防(PrEP)人群中的化学性行为:超越成瘾和风险,迈向健康性生活——西班牙巴塞罗那基于医院的 PrEP 项目的基线经验。
AIDS Behav. 2022 Dec;26(12):4055-4062. doi: 10.1007/s10461-022-03730-5. Epub 2022 Jun 22.
6
Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study.法国高危感染 HIV 男性人群中,暴露前预防的真实世界有效性:一项巢式病例对照研究。
Lancet Public Health. 2022 Jun;7(6):e529-e536. doi: 10.1016/S2468-2667(22)00106-2.
7
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations.口服暴露前预防(PrEP)预防 HIV:对所有人群的临床效果、安全性、依从性和风险补偿的系统评价和荟萃分析。
BMJ Open. 2022 May 11;12(5):e048478. doi: 10.1136/bmjopen-2020-048478.
8
Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).加拿大暴露前预防(PrEP)使用者的性行为与性传播感染的发生率在 l'Actuel PrEP 队列中(2013-2020 年)。
Sex Transm Infect. 2022 Dec;98(8):549-556. doi: 10.1136/sextrans-2021-055215. Epub 2022 Jan 17.
9
COVID-19 Pandemic, Pre-exposure Prophylaxis (PrEP) Care, and HIV/STI Testing Among Patients Receiving Care in Three HIV Epidemic Priority States.在三个艾滋病流行重点州接受治疗的患者中,新冠疫情、暴露前预防(PrEP)护理及艾滋病毒/性传播感染检测
AIDS Behav. 2021 May;25(5):1361-1365. doi: 10.1007/s10461-021-03195-y. Epub 2021 Feb 18.
10
HIV Prevention Responsibility Beliefs Among Men Who Have Sex With Men in the PrEP Era.《PrEP 时代男男性行为者的 HIV 预防责任信念》。
J Acquir Immune Defic Syndr. 2021 Jul 1;87(3):e222-e228. doi: 10.1097/QAI.0000000000002659.